| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
ALX Oncology Holdings (NASDAQ:ALXO) is set to give its latest quarterly earnings report on Friday, 2025-11-07. Here's what investors need to know before the announcement.
Analysts estimate that ALX Oncology Holdings will report an earnings per share (EPS) of $-0.37.
Investors in ALX Oncology Holdings are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
During the last quarter, the company reported an EPS missed by $0.07, leading to a 7.4% increase in the share price on the subsequent day.
Here's a look at ALX Oncology Holdings's past performance and the resulting price change:
| Quarter | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.37 | -0.340 | -0.39 | -0.78 |
| EPS Actual | -0.44 | -0.477 | -0.44 | -0.45 |
| Price Change % | 7.00 | -8.000 | -19.00 | -4.00 |
Shares of ALX Oncology Holdings were trading at $1.26 as of November 05. Over the last 52-week period, shares are down 15.17%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.
To track all earnings releases for ALX Oncology Holdings visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: ALXO
